Attitudes of obstetrician-gynecologists toward dna testing for a genetic susceptibility to breast cancer

Obstetrics and Gynecology

Volumn 88, Issue 4, 1996, Pages 611-615

  Rowley, Peter T ^a   Loader, Starlene ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ARTICLE; BREAST CARCINOMA; CANCER SCREENING; CHROMOSOME 17Q; DNA DETERMINATION; FAMILY HISTORY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MAMMOGRAPHY; MEDICAL SPECIALIST; PHYSICIAN ATTITUDE; PRIORITY JOURNAL;

EID: 0029833227     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00199-8     Document Type: Article

References (16)

1. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-9.
2. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266: 66-71.
3. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. JAMA 1995;273:535-41.
4. Easton DF, Bishop DT, Ford D, Crockford GP. and the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 1993;52: 678-701.
5. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57: 1457-62.
6. Lane DS, Burg MA. Breast cancer screening. Changing physician practices and specialty variation. N Y State J Med 1990;90:288-92.
7. King M-C, Rowell S, Love SM. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 1993;269:1975-80.
8. Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman LS, et al. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 1994;7: 103-7.
9. Cancer facts and figures: 1995. Atlanta, Georgia: American Cancer Society, 1995.
10. National Cancer Institute. Working guidelines for early detection: Rationale and supporting evidence to decrease mortality. Bethesda, Maryland: National Cancer Institute, 1987.
11. Chaliki H, Loader S, Levenkron JC, Logan-Young W, Hall WJ, Rowley PT. Women’s receptivity to testing for a genetic susceptibility to breast cancer. Am J Publ Health 1995;85: 1133-5.
12. Lerman C, Dalv M, Masny A, Balsham A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994; 12:843-50.
13. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, et al. Assessment and counseling for women with a family history of breast cancer. JAMA 1995;273:577-85.
14. Hudson KL, Rothenberg KG, Andrews LB, Kahn MJE, Collins FS, Brody LC. Genetic discrimination and health insurance: An urgent need for reform. Science 1995;270: 391-3.
15. The Ad Hoc Committee on Genetic Testing/Insurance Issues. Background statement: Genetic testing and insurance. Am J Hum Genet 1995;56: 327-31.
16. The American Society of Human Genetics Board of Directors and the American College of Medical Genetics Board of Directors. Points to consider: Ethical, legal and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 1995;57: 1233-1241.